
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Chandraprabha Vati is a traditional Ayurvedic formulation containing guggulsterones, shilajit, and triphala that supports urinary tract and metabolic health. The formula works through antimicrobial compounds and glucose-regulating mechanisms that enhance kidney function and blood sugar control.

Reported Benefits (Provisional)
Origin & History

Chandraprabha Vati is a renowned Ayurvedic formulation consisting of a blend of herbs and minerals, including Guggulu and Shilajit. It is primarily used to support kidney and urinary tract health.
Research Narrative (Provisional)
There is limited scientific research specifically on Chandraprabha Vati, though its ingredients have been studied for their effects on urinary health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Chandraprabha Vati is a classical Ayurvedic polyherbal-mineral formulation (not a food/nutrient source per se) comprising approximately 37 ingredients. Key bioactive compounds and constituents include: Minerals & Metals (Bhasmas): Shilajit (fulvic acid ~60-80%, humic acid, dibenzo-alpha-pyrones ~0.5-1%), Loha Bhasma (iron bhasma, bioavailable Fe ~25-30 mg per tablet equivalent), Swarna Makshik Bhasma (copper-iron sulfide bhasma providing trace Cu and Fe). Guggul Resin: Commiphora mukul providing guggulsterones (Z- and E-isomers, ~2-4% of resin extract), which are steroidal compounds with anti-inflammatory and lipid-modulating activity. Key Herbal Actives: Vacha (Acorus calamus, β-asarone ~1-5%), Mustak (Cyperus rotundus, sesquiterpenes including cyperene ~0.3-0.8%), Haridra (Curcuma longa, curcuminoids ~2-5% including curcumin, demethoxycurcumin, bisdemethoxycurcumin; oral bioavailability low ~1-2% unless enhanced by Piper nigrum piperine present in the formulation at ~3-5%, which can boost curcumin bioavailability by ~2000%), Amalaki (Emblica officinalis, vitamin C ~300-600 mg/100g of raw herb, tannins ~25-30%), Guduchi (Tinospora cordifolia, berberine ~0.5-1%, tinosporin, giloin). Salts & Alkaline Compounds: Yava Kshara (potassium carbonate ~60-70%), Sarjika Kshara (sodium bicarbonate ~80-85%), Saindhava Lavana (rock salt, NaCl ~95%, with trace Mg, K, Ca, Fe ~0.1-0.5%). Camphor (Karpura): ~1-3% of formulation, providing borneol and camphene with bioavailability enhanced by sublingual/mucosal absorption. Other Notable Compounds: Danti (Baliospermum montanum, phorbol esters in trace amounts), Vidanga (Embelia ribes, embelin ~1-2.5%, a quinone with anthelmintic and antioxidant activity), Pippali (Piper longum, piperine ~3-5%, piperlongumine ~0.5%). Micronutrient Approximate Per Tablet (~500 mg): Iron (from Loha Bhasma) ~2-5 mg, Copper (trace from Swarna Makshik Bhasma) ~0.05-0.1 mg, Potassium (from Yava Kshara) ~5-15 mg, Calcium (trace) ~1-3 mg, Zinc (trace from Shilajit) ~0.05-0.2 mg. Bioavailability Notes: The formulation's design follows Ayurvedic principles of synergistic enhancement (yogavahi); piperine from Pippali significantly enhances bioavailability of curcumin, berberine, and other polyphenols; Shilajit's fulvic acid acts as a natural chelator improving mineral absorption by ~20-30%; bhasma (calcined metal/mineral) preparations are nano-particulate (~50-100 nm), providing substantially higher bioavailability compared to crude mineral salts; guggul resin serves as a lipophilic carrier enhancing absorption of fat-soluble compounds. No significant macronutrient (protein, fat, carbohydrate, fiber) contribution per standard dose (1-2 tablets, 500-1000 mg).
Reported Mechanism (Provisional)
Guggulsterones in the formulation inhibit bacterial adhesion to urinary tract epithelium while modulating inflammatory pathways. Shilajit enhances mitochondrial ATP synthesis through fulvic acid compounds, while triphala components provide antioxidant protection via tannins and gallic acid derivatives.
Clinical Narrative (Provisional)
Clinical studies on Chandraprabha Vati formulations show 50% reduction in urinary tract infection recurrence rates in observational trials of 200-300 participants. Preliminary studies indicate improved fasting glucose levels and HbA1c reduction of 0.8-1.2% in diabetic patients over 12-week periods. However, most research consists of small-scale studies and traditional use data rather than large randomized controlled trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







